Table 1. Experimental design for the determination of hemostatic effects.
Group |
Treatment |
Samples (n) |
I (Normal control) |
Distilled water + 1% DMSO |
5 |
II (Positive control) |
StopsBleeding™* (0.50 mg/ml) |
5 |
III |
MECM (0.25mg/ml) |
5 |
IV |
MECM (0.50 mg/ml) |
5 |
V |
MECM (1 mg/ml) |
5 |
VI |
MELC (0.25mg/ml) |
5 |
VII |
MELC (0.50 mg/ml) |
5 |
VIII |
MELC (1 mg/ml) |
5 |
IX |
MECM-MELC (0.25mg/ml) |
5 |
X |
MECM-MELC (0.50 mg/ml) |
5 |
XI |
MECM-MELC (1mg/ml) |
5 |
MECM (methanol leaves extract of Croton megalocarpus), MELC (methanol leaves extract of Lantana camara), MECM-MELC (methanol blended leaves extract of Croton megalocarpus and Lantana camara). * The reference drug.